What is Emit Imaging?
EMIT Imaging is at the forefront of preclinical imaging, offering Cryo-Fluorescence Tomography (CFT) technology. Their platform, Xerra, automates the CFT workflow, providing high-resolution 3D imaging crucial for studying drug distribution and protein expression. This technology is vital for research in drug discovery, oncology, gene therapy, and neuroscience. The company supports researchers through both its advanced instrumentation and fee-for-service research capabilities, operating state-of-the-art labs in Boston and Baltimore.
How much funding has Emit Imaging raised?
Emit Imaging has raised a total of $7.1M across 1 funding round:
Private Equity
$7.1M
Private Equity (2025): $7.1M, investors not publicly disclosed
What's next for Emit Imaging?
The substantial enterprise-level funding positions Emit Imaging for significant expansion and further technological development. This capital infusion is expected to bolster their research and development efforts, enhance their market reach, and potentially scale their operations to meet the increasing demand for sophisticated preclinical imaging solutions. The company's focus on critical therapeutic areas suggests a strategic growth trajectory aimed at solidifying its role as a key player in the life sciences sector.
See full Emit Imaging company page
